To Evaluate the Efficacy and Safety of Collavant n2 in Individuals With Osteoarthritis of the Knee

NCT05474586 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

236

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

OTHER: Collavant n2 40 mg/day
OTHER: Glucosamine hydrochloride & Chondroitin sulfate
OTHER: Microcrystalline cellulose

Sponsor

Vedic Lifesciences Pvt. Ltd.